JYSZ2200035 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
JYSB2500007 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2101100 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2500006 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2101101 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSZ2200036 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
JYSB2101102 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSZ2200034 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
JYSB2500004 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2101103 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSZ2200033 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
JYSB2500005 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-01-04 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JXSL0900022 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Import Drug Application | 2009-05-18 | | Wyeth Europa Ltd | Certificate Issued | 2010-05-13 | view |
JXSL0900023 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Import Drug Application | 2009-05-06 | | Wyeth Europa Ltd | Certificate Issued | 2010-05-13 | view |
JXSL0900025 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Import Drug Application | 2009-05-06 | | Wyeth Europa Ltd | Certificate Issued | 2010-05-13 | view |
JXSL0900024 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Import Drug Application | 2009-05-06 | | Wyeth Europa Ltd | Certificate Issued | 2010-07-06 | view |
JXSS1000017 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Import Drug Application | 2010-10-28 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2012-07-18 | view |
JXSS1000015 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Import Drug Application | 2010-10-28 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2012-07-18 | view |
JXSS1000014 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Import Drug Application | 2010-10-28 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2012-07-18 | view |
JXSS1000016 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Import Drug Application | 2010-10-28 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2012-07-18 | view |